Suchergebnisse - "Motoi, Noriko"

PubPharm (14)

1

Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations

enthalten in: Cancer research communications | 2023

von Aoki, K. | Nishito, Y. | Motoi, N. | +38

2

Concurrent High PD-L1 Expression and CD8+ Immune Cell Infiltration Predict PD-1 Blockade Efficacy in Advanced EGFR-Mutant NSCLC Patients

enthalten in: Clinical lung cancer | 2022

von Shimoda, Y. | Shibaki, R. | Yoshida, T. | +12

3

Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions

enthalten in: Scientific reports | 2021

von Morita, C. | Yoshida, T. | Shirasawa, M. | +11

4

HSP90 inhibition overcomes EGFR amplification-induced resistance to third-generation EGFR-TKIs

enthalten in: Thoracic cancer | 2021

von Watanabe, S. | Goto, Y. | Yasuda, H. | +7

5

Disease flare of leptomeningeal metastases without radiological and cytological findings after the discontinuation of osimertinib

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Takahashi, T. | Umeguchi, H. | Tateishi, A. | +3

6

High expression of programmed cell death 1 ligand 1 in lung adenocarcinoma is a poor prognostic factor particularly in smokers and wild-type epidermal growth-factor receptor cases

enthalten in: Pathology international | 2017

von Mori, S. | Motoi, N. | Ninomiya, H. | +7

ErratumIn: Pathol Int. 2017 Apr;67(4):234. - PMID 28370983

7

Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2016

von Horiike, A. | Takeuchi, K. | Uenami, T. | +11

8

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

enthalten in: EBioMedicine | 2016

von Katayama, R. | Sakashita, T. | Yanagitani, N. | +19

9

Pulmonary adenocarcinoma in situ : analyses of a large series with reference to smoking, driver mutations, and receptor tyrosine kinase pathway activation

enthalten in: The American journal of surgical pathology | 2015

von Sato, S. | Motoi, N. | Hiramatsu, M. | +12

10

Pemetrexed and cisplatin for advanced non-squamous non-small cell lung cancer in Japanese patients : phase II study

enthalten in: Anticancer research | 2013

von Kawano, Y. | Ohyanagi, F. | Yanagitani, N. | +13

ErratumIn: Anticancer Res. 2013 Sep;33(9):4137